Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: PULMOKINE, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2013-11-14 to 2016-11-14
Current total value of award: $1549476.97
Description: VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): IND ENABLING STUDIES FOR A NOVEL INHALED PDGF RECEPTOR INHIBITOR TO TREAT PAH